Atossa Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $41.3M | $71.1M | $88.5M | $110.9M | $136.4M | $39.6M | $12.6M | $10.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $45.6M | $74.5M | $92.2M | $118.2M | $141.2M | $42.8M | $14.3M | $11.5M |
| Property, Plant & Equipment | — | — | — | — | $20.0K | $21.0K | $34.4K | $54.5K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $54.0K | $41.0K | $173.5K | $192.0K |
| Total Assets | $47.6M | $76.4M | $96.3M | $123.5M | $141.3M | $42.8M | $14.5M | $11.7M |
| Liabilities | ||||||||
| Accounts Payable | $4.3M | $679.0K | $806.0K | $3.0M | $1.7M | $1.6M | $293.2K | $353.3K |
| Total Current Liabilities | $8.3M | $5.0M | $5.2M | $5.6M | $3.1M | $15.7M | $1.3M | $2.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $8.3M | $5.0M | $5.2M | $5.6M | $3.1M | $15.7M | $1.3M | $2.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-246.6M | $-211.8M | $-186.3M | $-156.2M | $-129.2M | $-111.9M | $-94.1M | $-76.8M |
| Total Stockholders' Equity | $39.4M | $71.5M | $91.0M | $118.0M | $138.1M | $27.2M | $13.2M | $8.8M |